Cargando…
Erenumab safety and efficacy in migraine: A systematic review and meta-analysis of randomized clinical trials
BACKGROUND: Erenumab is a new medicine recently approved in the United States of America for the preventive treatment of migraine among adults. We aimed to conduct a meta-analysis and evaluation of the efficacy and safety of erenumab among patients with migraine. METHODS: The electronic databases th...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6946432/ https://www.ncbi.nlm.nih.gov/pubmed/31876735 http://dx.doi.org/10.1097/MD.0000000000018483 |